TP53 and cancer: The pathway Cell cycle that induces proliferation was downregulated, while the tumor-suppressive pathway p53 was upregulated by a higher number of p53-effector lncRNAs across the cancer types than the number of lncRNAs that had the opposite impact (Supplementary Fig. S3; Supplementary Tables S5 and S6).